PACS Group, Inc.
Get $10 bonus on your first $100 deposit for PACS
Get $10 bonus on your first $100 deposit for PACS
PACS Group, Inc. (PACS) Stock Competitors & Peer Comparison
See (PACS) competitors and their performances in Stock Market.
Peer Comparison Table: Financial - Conglomerates Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PACS | $35.20 | +2.55% | 5.5B | 28.88 | $1.22 | N/A |
| TPGXL | $25.14 | +0.20% | 23.8B | N/A | N/A | +4.61% |
| VOYA-PB | $23.85 | +0.08% | 7.3B | 2.84 | $8.44 | +2.47% |
| VOYA | $74.45 | +2.25% | 7.1B | 11.84 | $6.29 | +2.47% |
| BIPH | $16.50 | +0.55% | 6B | N/A | N/A | +7.55% |
| MSDL | $15.36 | +0.66% | 1.3B | 10.98 | $1.40 | +12.68% |
| RILYK | $25.23 | +0.16% | 787.6M | N/A | N/A | N/A |
| RILYN | $24.29 | +0.02% | 758.3M | N/A | N/A | N/A |
| RILYM | $25.11 | +0.00% | 753M | N/A | N/A | N/A |
| RILYG | $23.40 | -0.38% | 730.5M | N/A | N/A | N/A |
Stock Comparison
PACS vs TPGXL Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, TPGXL has a market cap of 23.8B. Regarding current trading prices, PACS is priced at $35.20, while TPGXL trades at $25.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas TPGXL's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to TPGXL's ROE of +0.16%. Regarding short-term risk, PACS is more volatile compared to TPGXL. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check TPGXL's competition here
PACS vs VOYA-PB Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, VOYA-PB has a market cap of 7.3B. Regarding current trading prices, PACS is priced at $35.20, while VOYA-PB trades at $23.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas VOYA-PB's P/E ratio is 2.84. In terms of profitability, PACS's ROE is +0.23%, compared to VOYA-PB's ROE of +0.14%. Regarding short-term risk, PACS is more volatile compared to VOYA-PB. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check VOYA-PB's competition here
PACS vs VOYA Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, VOYA has a market cap of 7.1B. Regarding current trading prices, PACS is priced at $35.20, while VOYA trades at $74.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas VOYA's P/E ratio is 11.84. In terms of profitability, PACS's ROE is +0.23%, compared to VOYA's ROE of +0.14%. Regarding short-term risk, PACS is more volatile compared to VOYA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check VOYA's competition here
PACS vs BIPH Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, BIPH has a market cap of 6B. Regarding current trading prices, PACS is priced at $35.20, while BIPH trades at $16.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas BIPH's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to BIPH's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to BIPH. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BIPH's competition here
PACS vs MSDL Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, MSDL has a market cap of 1.3B. Regarding current trading prices, PACS is priced at $35.20, while MSDL trades at $15.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas MSDL's P/E ratio is 10.98. In terms of profitability, PACS's ROE is +0.23%, compared to MSDL's ROE of +0.07%. Regarding short-term risk, PACS is more volatile compared to MSDL. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MSDL's competition here
PACS vs RILYK Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, RILYK has a market cap of 787.6M. Regarding current trading prices, PACS is priced at $35.20, while RILYK trades at $25.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas RILYK's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to RILYK's ROE of -0.96%. Regarding short-term risk, PACS is more volatile compared to RILYK. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYK's competition here
PACS vs RILYN Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, RILYN has a market cap of 758.3M. Regarding current trading prices, PACS is priced at $35.20, while RILYN trades at $24.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas RILYN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to RILYN's ROE of -0.96%. Regarding short-term risk, PACS is more volatile compared to RILYN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYN's competition here
PACS vs RILYM Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, RILYM has a market cap of 753M. Regarding current trading prices, PACS is priced at $35.20, while RILYM trades at $25.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas RILYM's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to RILYM's ROE of -0.96%. Regarding short-term risk, PACS is more volatile compared to RILYM. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYM's competition here
PACS vs RILYG Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, RILYG has a market cap of 730.5M. Regarding current trading prices, PACS is priced at $35.20, while RILYG trades at $23.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas RILYG's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to RILYG's ROE of -0.96%. Regarding short-term risk, PACS is more volatile compared to RILYG. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYG's competition here
PACS vs BBCQW Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, BBCQW has a market cap of 730.3M. Regarding current trading prices, PACS is priced at $35.20, while BBCQW trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas BBCQW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to BBCQW's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to BBCQW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check BBCQW's competition here
PACS vs TREE Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, TREE has a market cap of 664.5M. Regarding current trading prices, PACS is priced at $35.20, while TREE trades at $47.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas TREE's P/E ratio is 4.45. In terms of profitability, PACS's ROE is +0.23%, compared to TREE's ROE of +0.94%. Regarding short-term risk, PACS is more volatile compared to TREE. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check TREE's competition here
PACS vs RILYO Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, RILYO has a market cap of 573.5M. Regarding current trading prices, PACS is priced at $35.20, while RILYO trades at $25.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas RILYO's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to RILYO's ROE of -0.96%. Regarding short-term risk, PACS is more volatile compared to RILYO. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYO's competition here
PACS vs RILYT Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, RILYT has a market cap of 562.9M. Regarding current trading prices, PACS is priced at $35.20, while RILYT trades at $18.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas RILYT's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to RILYT's ROE of -0.96%. Regarding short-term risk, PACS is more volatile compared to RILYT. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYT's competition here
PACS vs NWAX Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, NWAX has a market cap of 501.7M. Regarding current trading prices, PACS is priced at $35.20, while NWAX trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas NWAX's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to NWAX's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to NWAX. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check NWAX's competition here
PACS vs CRAN Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, CRAN has a market cap of 467.6M. Regarding current trading prices, PACS is priced at $35.20, while CRAN trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas CRAN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to CRAN's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to CRAN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CRAN's competition here
PACS vs PLMKW Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, PLMKW has a market cap of 444.8M. Regarding current trading prices, PACS is priced at $35.20, while PLMKW trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas PLMKW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to PLMKW's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to PLMKW. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PLMKW's competition here
PACS vs MESH Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, MESH has a market cap of 427.8M. Regarding current trading prices, PACS is priced at $35.20, while MESH trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas MESH's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to MESH's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MESH. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MESH's competition here
PACS vs CCXIU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, CCXIU has a market cap of 426.5M. Regarding current trading prices, PACS is priced at $35.20, while CCXIU trades at $10.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas CCXIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to CCXIU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to CCXIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CCXIU's competition here
PACS vs CCXI Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, CCXI has a market cap of 426.2M. Regarding current trading prices, PACS is priced at $35.20, while CCXI trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas CCXI's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to CCXI's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to CCXI. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CCXI's competition here
PACS vs ANSCU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, ANSCU has a market cap of 396.8M. Regarding current trading prices, PACS is priced at $35.20, while ANSCU trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas ANSCU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to ANSCU's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to ANSCU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ANSCU's competition here
PACS vs BBCQ Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, BBCQ has a market cap of 392.9M. Regarding current trading prices, PACS is priced at $35.20, while BBCQ trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas BBCQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to BBCQ's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to BBCQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BBCQ's competition here
PACS vs DBCAU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, DBCAU has a market cap of 380.3M. Regarding current trading prices, PACS is priced at $35.20, while DBCAU trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas DBCAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to DBCAU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to DBCAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DBCAU's competition here
PACS vs RILYL Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, RILYL has a market cap of 366.7M. Regarding current trading prices, PACS is priced at $35.20, while RILYL trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas RILYL's P/E ratio is 2.00. In terms of profitability, PACS's ROE is +0.23%, compared to RILYL's ROE of -0.96%. Regarding short-term risk, PACS is more volatile compared to RILYL. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYL's competition here
PACS vs NWAX-UN Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, NWAX-UN has a market cap of 362.9M. Regarding current trading prices, PACS is priced at $35.20, while NWAX-UN trades at $10.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas NWAX-UN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to NWAX-UN's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to NWAX-UN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check NWAX-UN's competition here
PACS vs CRANU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, CRANU has a market cap of 359.3M. Regarding current trading prices, PACS is priced at $35.20, while CRANU trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas CRANU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to CRANU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to CRANU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CRANU's competition here
PACS vs RILYP Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, RILYP has a market cap of 358.4M. Regarding current trading prices, PACS is priced at $35.20, while RILYP trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas RILYP's P/E ratio is 1.95. In terms of profitability, PACS's ROE is +0.23%, compared to RILYP's ROE of -0.96%. Regarding short-term risk, PACS is less volatile compared to RILYP. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check RILYP's competition here
PACS vs SBXE Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SBXE has a market cap of 344.2M. Regarding current trading prices, PACS is priced at $35.20, while SBXE trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SBXE's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SBXE's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to SBXE. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SBXE's competition here
PACS vs ARCI Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, ARCI has a market cap of 339M. Regarding current trading prices, PACS is priced at $35.20, while ARCI trades at $9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas ARCI's P/E ratio is -4297.83. In terms of profitability, PACS's ROE is +0.23%, compared to ARCI's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to ARCI. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ARCI's competition here
PACS vs DSAC Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, DSAC has a market cap of 337.5M. Regarding current trading prices, PACS is priced at $35.20, while DSAC trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas DSAC's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to DSAC's ROE of +0.11%. Regarding short-term risk, PACS is more volatile compared to DSAC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DSAC's competition here
PACS vs POLEU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, POLEU has a market cap of 317.1M. Regarding current trading prices, PACS is priced at $35.20, while POLEU trades at $10.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas POLEU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to POLEU's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to POLEU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check POLEU's competition here
PACS vs SAC Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SAC has a market cap of 312.7M. Regarding current trading prices, PACS is priced at $35.20, while SAC trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SAC's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SAC's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to SAC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SAC's competition here
PACS vs KBONU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, KBONU has a market cap of 306.3M. Regarding current trading prices, PACS is priced at $35.20, while KBONU trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas KBONU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to KBONU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to KBONU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check KBONU's competition here
PACS vs DBCA Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, DBCA has a market cap of 305.6M. Regarding current trading prices, PACS is priced at $35.20, while DBCA trades at $9.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas DBCA's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to DBCA's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to DBCA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DBCA's competition here
PACS vs ALOVU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, ALOVU has a market cap of 300.8M. Regarding current trading prices, PACS is priced at $35.20, while ALOVU trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas ALOVU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to ALOVU's ROE of +1.47%. Regarding short-term risk, PACS is more volatile compared to ALOVU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ALOVU's competition here
PACS vs PLMKU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, PLMKU has a market cap of 297.7M. Regarding current trading prices, PACS is priced at $35.20, while PLMKU trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas PLMKU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to PLMKU's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to PLMKU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PLMKU's competition here
PACS vs HACQ Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, HACQ has a market cap of 284.9M. Regarding current trading prices, PACS is priced at $35.20, while HACQ trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas HACQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to HACQ's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to HACQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HACQ's competition here
PACS vs BEAGU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, BEAGU has a market cap of 280.9M. Regarding current trading prices, PACS is priced at $35.20, while BEAGU trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas BEAGU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to BEAGU's ROE of +0.07%. Regarding short-term risk, PACS is more volatile compared to BEAGU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BEAGU's competition here
PACS vs XCBE Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, XCBE has a market cap of 279.7M. Regarding current trading prices, PACS is priced at $35.20, while XCBE trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas XCBE's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to XCBE's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to XCBE. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check XCBE's competition here
PACS vs RILY Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, RILY has a market cap of 274.2M. Regarding current trading prices, PACS is priced at $35.20, while RILY trades at $7.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas RILY's P/E ratio is 1.04. In terms of profitability, PACS's ROE is +0.23%, compared to RILY's ROE of -0.96%. Regarding short-term risk, PACS is less volatile compared to RILY. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check RILY's competition here
PACS vs XSLL Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, XSLL has a market cap of 272.6M. Regarding current trading prices, PACS is priced at $35.20, while XSLL trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas XSLL's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to XSLL's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to XSLL. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check XSLL's competition here
PACS vs HVII Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, HVII has a market cap of 270.8M. Regarding current trading prices, PACS is priced at $35.20, while HVII trades at $10.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas HVII's P/E ratio is 69.37. In terms of profitability, PACS's ROE is +0.23%, compared to HVII's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to HVII. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HVII's competition here
PACS vs FACTU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, FACTU has a market cap of 268.7M. Regarding current trading prices, PACS is priced at $35.20, while FACTU trades at $10.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas FACTU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to FACTU's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to FACTU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check FACTU's competition here
PACS vs MLAA Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, MLAA has a market cap of 262.3M. Regarding current trading prices, PACS is priced at $35.20, while MLAA trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas MLAA's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to MLAA's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MLAA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MLAA's competition here
PACS vs SORN Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SORN has a market cap of 261.4M. Regarding current trading prices, PACS is priced at $35.20, while SORN trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SORN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SORN's ROE of +1.43%. Regarding short-term risk, PACS is more volatile compared to SORN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SORN's competition here
PACS vs GIXXU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, GIXXU has a market cap of 258.2M. Regarding current trading prices, PACS is priced at $35.20, while GIXXU trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas GIXXU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to GIXXU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to GIXXU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check GIXXU's competition here
PACS vs ALOV Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, ALOV has a market cap of 257.9M. Regarding current trading prices, PACS is priced at $35.20, while ALOV trades at $9.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas ALOV's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to ALOV's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to ALOV. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ALOV's competition here
PACS vs DMAAU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, DMAAU has a market cap of 257.1M. Regarding current trading prices, PACS is priced at $35.20, while DMAAU trades at $10.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas DMAAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to DMAAU's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to DMAAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DMAAU's competition here
PACS vs PLMK Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, PLMK has a market cap of 256.7M. Regarding current trading prices, PACS is priced at $35.20, while PLMK trades at $10.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas PLMK's P/E ratio is 40.73. In terms of profitability, PACS's ROE is +0.23%, compared to PLMK's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to PLMK. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PLMK's competition here
PACS vs HVIIU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, HVIIU has a market cap of 253.8M. Regarding current trading prices, PACS is priced at $35.20, while HVIIU trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas HVIIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to HVIIU's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to HVIIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HVIIU's competition here
PACS vs AACI Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, AACI has a market cap of 252.5M. Regarding current trading prices, PACS is priced at $35.20, while AACI trades at $9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas AACI's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to AACI's ROE of +2.44%. Regarding short-term risk, PACS is more volatile compared to AACI. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check AACI's competition here
PACS vs ACAAU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, ACAAU has a market cap of 252.5M. Regarding current trading prices, PACS is priced at $35.20, while ACAAU trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas ACAAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to ACAAU's ROE of +1.52%. Regarding short-term risk, PACS is more volatile compared to ACAAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ACAAU's competition here
PACS vs PTOR Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, PTOR has a market cap of 250.1M. Regarding current trading prices, PACS is priced at $35.20, while PTOR trades at $9.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas PTOR's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to PTOR's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to PTOR. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PTOR's competition here
PACS vs OIMAW Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, OIMAW has a market cap of 250M. Regarding current trading prices, PACS is priced at $35.20, while OIMAW trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas OIMAW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to OIMAW's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to OIMAW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check OIMAW's competition here
PACS vs HCICU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, HCICU has a market cap of 247.7M. Regarding current trading prices, PACS is priced at $35.20, while HCICU trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas HCICU's P/E ratio is 42.83. In terms of profitability, PACS's ROE is +0.23%, compared to HCICU's ROE of -0.78%. Regarding short-term risk, PACS is more volatile compared to HCICU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HCICU's competition here
PACS vs DRDB Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, DRDB has a market cap of 241.8M. Regarding current trading prices, PACS is priced at $35.20, while DRDB trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas DRDB's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to DRDB's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to DRDB. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DRDB's competition here
PACS vs SBXE-UN Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SBXE-UN has a market cap of 241.4M. Regarding current trading prices, PACS is priced at $35.20, while SBXE-UN trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SBXE-UN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SBXE-UN's ROE of -0.06%. Regarding short-term risk, PACS is more volatile compared to SBXE-UN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SBXE-UN's competition here
PACS vs SAAQ Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SAAQ has a market cap of 240.2M. Regarding current trading prices, PACS is priced at $35.20, while SAAQ trades at $10.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SAAQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SAAQ's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to SAAQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SAAQ's competition here
PACS vs IRHO Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, IRHO has a market cap of 233.5M. Regarding current trading prices, PACS is priced at $35.20, while IRHO trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas IRHO's P/E ratio is 247.62. In terms of profitability, PACS's ROE is +0.23%, compared to IRHO's ROE of +1.87%. Regarding short-term risk, PACS is more volatile compared to IRHO. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check IRHO's competition here
PACS vs CAQ Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, CAQ has a market cap of 231.4M. Regarding current trading prices, PACS is priced at $35.20, while CAQ trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas CAQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to CAQ's ROE of +9.93%. Regarding short-term risk, PACS is more volatile compared to CAQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CAQ's competition here
PACS vs ADAC Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, ADAC has a market cap of 229.1M. Regarding current trading prices, PACS is priced at $35.20, while ADAC trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas ADAC's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to ADAC's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to ADAC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ADAC's competition here
PACS vs LPCV Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, LPCV has a market cap of 228.4M. Regarding current trading prices, PACS is priced at $35.20, while LPCV trades at $9.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas LPCV's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to LPCV's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to LPCV. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check LPCV's competition here
PACS vs VHCP Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, VHCP has a market cap of 228.2M. Regarding current trading prices, PACS is priced at $35.20, while VHCP trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas VHCP's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to VHCP's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to VHCP. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check VHCP's competition here
PACS vs BLRK Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, BLRK has a market cap of 227.9M. Regarding current trading prices, PACS is priced at $35.20, while BLRK trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas BLRK's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to BLRK's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to BLRK. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BLRK's competition here
PACS vs ITHA Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, ITHA has a market cap of 227.9M. Regarding current trading prices, PACS is priced at $35.20, while ITHA trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas ITHA's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to ITHA's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to ITHA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ITHA's competition here
PACS vs BIII Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, BIII has a market cap of 227.2M. Regarding current trading prices, PACS is priced at $35.20, while BIII trades at $9.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas BIII's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to BIII's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to BIII. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BIII's competition here
PACS vs MEVOU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, MEVOU has a market cap of 225.9M. Regarding current trading prices, PACS is priced at $35.20, while MEVOU trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas MEVOU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to MEVOU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MEVOU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MEVOU's competition here
PACS vs SSACU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SSACU has a market cap of 221.4M. Regarding current trading prices, PACS is priced at $35.20, while SSACU trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SSACU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SSACU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to SSACU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SSACU's competition here
PACS vs SVAQ Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SVAQ has a market cap of 219.6M. Regarding current trading prices, PACS is priced at $35.20, while SVAQ trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SVAQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SVAQ's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SVAQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SVAQ's competition here
PACS vs PTORU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, PTORU has a market cap of 219.1M. Regarding current trading prices, PACS is priced at $35.20, while PTORU trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas PTORU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to PTORU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to PTORU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PTORU's competition here
PACS vs GIX Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, GIX has a market cap of 216.6M. Regarding current trading prices, PACS is priced at $35.20, while GIX trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas GIX's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to GIX's ROE of +2.26%. Regarding short-term risk, PACS is more volatile compared to GIX. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check GIX's competition here
PACS vs APLMW Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, APLMW has a market cap of 215.8M. Regarding current trading prices, PACS is priced at $35.20, while APLMW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas APLMW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to APLMW's ROE of -133.85%. Regarding short-term risk, PACS is more volatile compared to APLMW. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check APLMW's competition here
PACS vs DRDBU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, DRDBU has a market cap of 211.8M. Regarding current trading prices, PACS is priced at $35.20, while DRDBU trades at $10.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas DRDBU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to DRDBU's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to DRDBU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DRDBU's competition here
PACS vs MUZE Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, MUZE has a market cap of 203M. Regarding current trading prices, PACS is priced at $35.20, while MUZE trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas MUZE's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to MUZE's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MUZE. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MUZE's competition here
PACS vs SAC-UN Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SAC-UN has a market cap of 202.2M. Regarding current trading prices, PACS is priced at $35.20, while SAC-UN trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SAC-UN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SAC-UN's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SAC-UN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SAC-UN's competition here
PACS vs XCBEU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, XCBEU has a market cap of 200.4M. Regarding current trading prices, PACS is priced at $35.20, while XCBEU trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas XCBEU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to XCBEU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to XCBEU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check XCBEU's competition here
PACS vs IPEXR Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, IPEXR has a market cap of 200.4M. Regarding current trading prices, PACS is priced at $35.20, while IPEXR trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas IPEXR's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to IPEXR's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to IPEXR. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check IPEXR's competition here
PACS vs TRGSU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, TRGSU has a market cap of 200M. Regarding current trading prices, PACS is priced at $35.20, while TRGSU trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas TRGSU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to TRGSU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to TRGSU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check TRGSU's competition here
PACS vs WLII Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, WLII has a market cap of 198.4M. Regarding current trading prices, PACS is priced at $35.20, while WLII trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas WLII's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to WLII's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to WLII. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check WLII's competition here
PACS vs NTWOU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, NTWOU has a market cap of 189.9M. Regarding current trading prices, PACS is priced at $35.20, while NTWOU trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas NTWOU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to NTWOU's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to NTWOU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check NTWOU's competition here
PACS vs PAAC Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, PAAC has a market cap of 181.2M. Regarding current trading prices, PACS is priced at $35.20, while PAAC trades at $9.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas PAAC's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to PAAC's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to PAAC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PAAC's competition here
PACS vs ETHM Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, ETHM has a market cap of 179.4M. Regarding current trading prices, PACS is priced at $35.20, while ETHM trades at $10.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas ETHM's P/E ratio is -13.51. In terms of profitability, PACS's ROE is +0.23%, compared to ETHM's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to ETHM. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ETHM's competition here
PACS vs MUZEU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, MUZEU has a market cap of 178.9M. Regarding current trading prices, PACS is priced at $35.20, while MUZEU trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas MUZEU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to MUZEU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MUZEU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MUZEU's competition here
PACS vs AACPU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, AACPU has a market cap of 178.2M. Regarding current trading prices, PACS is priced at $35.20, while AACPU trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas AACPU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to AACPU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to AACPU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check AACPU's competition here
PACS vs SCII Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SCII has a market cap of 174.9M. Regarding current trading prices, PACS is priced at $35.20, while SCII trades at $9.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SCII's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SCII's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SCII. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SCII's competition here
PACS vs IRAB Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, IRAB has a market cap of 171M. Regarding current trading prices, PACS is priced at $35.20, while IRAB trades at $9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas IRAB's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to IRAB's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to IRAB. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check IRAB's competition here
PACS vs RANG Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, RANG has a market cap of 169.4M. Regarding current trading prices, PACS is priced at $35.20, while RANG trades at $10.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas RANG's P/E ratio is 42.24. In terms of profitability, PACS's ROE is +0.23%, compared to RANG's ROE of +0.05%. Regarding short-term risk, PACS is less volatile compared to RANG. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check RANG's competition here
PACS vs SVCCU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SVCCU has a market cap of 164.1M. Regarding current trading prices, PACS is priced at $35.20, while SVCCU trades at $10.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SVCCU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SVCCU's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to SVCCU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SVCCU's competition here
PACS vs TAVIU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, TAVIU has a market cap of 154.5M. Regarding current trading prices, PACS is priced at $35.20, while TAVIU trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas TAVIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to TAVIU's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to TAVIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check TAVIU's competition here
PACS vs CTAAU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, CTAAU has a market cap of 154.4M. Regarding current trading prices, PACS is priced at $35.20, while CTAAU trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas CTAAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to CTAAU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to CTAAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CTAAU's competition here
PACS vs BSIIU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, BSIIU has a market cap of 152.8M. Regarding current trading prices, PACS is priced at $35.20, while BSIIU trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas BSIIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to BSIIU's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to BSIIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BSIIU's competition here
PACS vs SUMAU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SUMAU has a market cap of 150.8M. Regarding current trading prices, PACS is priced at $35.20, while SUMAU trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SUMAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SUMAU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SUMAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SUMAU's competition here
PACS vs TDWD Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, TDWD has a market cap of 149.3M. Regarding current trading prices, PACS is priced at $35.20, while TDWD trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas TDWD's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to TDWD's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to TDWD. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check TDWD's competition here
PACS vs SCPQ Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SCPQ has a market cap of 136.1M. Regarding current trading prices, PACS is priced at $35.20, while SCPQ trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SCPQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SCPQ's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SCPQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SCPQ's competition here
PACS vs SORNW Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SORNW has a market cap of 135.7M. Regarding current trading prices, PACS is priced at $35.20, while SORNW trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SORNW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SORNW's ROE of +0.00%. Regarding short-term risk, PACS is less volatile compared to SORNW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check SORNW's competition here
PACS vs SPHA Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SPHA has a market cap of 111.7M. Regarding current trading prices, PACS is priced at $35.20, while SPHA trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SPHA's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SPHA's ROE of -2.76%. Regarding short-term risk, PACS is more volatile compared to SPHA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SPHA's competition here
PACS vs BHAVU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, BHAVU has a market cap of 108.3M. Regarding current trading prices, PACS is priced at $35.20, while BHAVU trades at $10.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas BHAVU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to BHAVU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to BHAVU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BHAVU's competition here
PACS vs ACOG Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, ACOG has a market cap of 105.9M. Regarding current trading prices, PACS is priced at $35.20, while ACOG trades at $6.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas ACOG's P/E ratio is -5.78. In terms of profitability, PACS's ROE is +0.23%, compared to ACOG's ROE of -0.49%. Regarding short-term risk, PACS is less volatile compared to ACOG. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check ACOG's competition here
PACS vs SCPQU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, SCPQU has a market cap of 103.6M. Regarding current trading prices, PACS is priced at $35.20, while SCPQU trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas SCPQU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to SCPQU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SCPQU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SCPQU's competition here
PACS vs RFAMU Comparison April 2026
PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PACS stands at 5.5B. In comparison, RFAMU has a market cap of 102.6M. Regarding current trading prices, PACS is priced at $35.20, while RFAMU trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PACS currently has a P/E ratio of 28.88, whereas RFAMU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.23%, compared to RFAMU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to RFAMU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RFAMU's competition here